Pub Date : 2024-03-30DOI: 10.1016/j.bosn.2024.03.002
Shyam Kumar Sudhakar, Kaustav Mehta
Traumatic brain injuries (TBIs) are characterized by widespread complications that exert a debilitating effect on the well-being of the affected individual. TBIs are associated with a multitude of psychiatric and medical comorbidities over the long term. Furthermore, no medications prevent secondary injuries associated with a primary insult. In this perspective article, we propose applying graph theory via the construction of disease comorbidity networks to identify high-risk patient groups, offer preventive care to affected populations, and reduce the disease burden. We describe the challenges associated with monitoring the development of comorbidities in TBI subjects and explain how disease comorbidity networks can reduce disease burden by preventing disease-related complications. We further discuss the various methods used to construct disease comorbidity networks and explain how features derived from a network can help identify subjects who might be at risk of developing post-traumatic comorbidities. Lastly, we address the potential challenges of using graph theory to successfully manage comorbidities following a TBI.
{"title":"Charting paths to recovery: Navigating traumatic brain injury comorbidities through graph theory–exploring benefits and challenges","authors":"Shyam Kumar Sudhakar, Kaustav Mehta","doi":"10.1016/j.bosn.2024.03.002","DOIUrl":"10.1016/j.bosn.2024.03.002","url":null,"abstract":"<div><p>Traumatic brain injuries (TBIs) are characterized by widespread complications that exert a debilitating effect on the well-being of the affected individual. TBIs are associated with a multitude of psychiatric and medical comorbidities over the long term. Furthermore, no medications prevent secondary injuries associated with a primary insult. In this perspective article, we propose applying graph theory via the construction of disease comorbidity networks to identify high-risk patient groups, offer preventive care to affected populations, and reduce the disease burden. We describe the challenges associated with monitoring the development of comorbidities in TBI subjects and explain how disease comorbidity networks can reduce disease burden by preventing disease-related complications. We further discuss the various methods used to construct disease comorbidity networks and explain how features derived from a network can help identify subjects who might be at risk of developing post-traumatic comorbidities. Lastly, we address the potential challenges of using graph theory to successfully manage comorbidities following a TBI.</p></div>","PeriodicalId":100198,"journal":{"name":"Brain Organoid and Systems Neuroscience Journal","volume":"2 ","pages":"Pages 10-16"},"PeriodicalIF":0.0,"publicationDate":"2024-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2949921624000024/pdfft?md5=9b493993309927962a8ce75a9a1bf518&pid=1-s2.0-S2949921624000024-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140405895","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-03-14DOI: 10.1016/j.bosn.2024.03.001
Duarte Oliveira-Saraiva, Hugo Alexandre Ferreira
In the big data era, with a lack of comparable functional neuroimaging data, researchers try to combine heterogeneous data of different lengths, trimming those to the same number of timepoints (NTPs). However, the effects of trimming blood-oxygen-level dependent (BOLD) signal data on functional connectivity (FC) are still poorly understood.
Resting-state functional magnetic resonance imaging data from thirty healthy subjects were pre-processed for five different NTPs, from which FC matrices were computed. These BOLD signal correlation matrices were binarized for several thresholds, excluding weak correlations. Graph metrics were computed to study FC differences between different NTPs. The study included node degree analysis for each brain region and assessment of small-worldness coefficients ( and ), whereas in small-world networks, characteristic values are > 1 and 0, indicating a balance between high clustering coefficients and short characteristic path lengths.
A tendency of decreasing global network degrees for higher NTPs was observed, translating the loss of stronger correlations with longer BOLD signals. Trimming such data affects brain regions differently, probably due to brain network dynamics. Regarding small-worldness, we observed that was greater than 1 for all the different NTPs, showing an increasing trend for higher NTPs (median value: 3.05). In addition, consistently remained greater than 0 for all NTPs, gradually approaching 0 as the NTPs increased (median value 0.20). As such, the results suggest a tendency for an increase of small-world properties for increasing NTPs. Nonetheless, the overall properties of brain networks almost remain constant. In conclusion, trimming BOLD signal data leads to small differences in FC.
{"title":"Effect of blood oxygen-level-dependent signal data trimming on functional connectivity metrics","authors":"Duarte Oliveira-Saraiva, Hugo Alexandre Ferreira","doi":"10.1016/j.bosn.2024.03.001","DOIUrl":"10.1016/j.bosn.2024.03.001","url":null,"abstract":"<div><p>In the big data era, with a lack of comparable functional neuroimaging data, researchers try to combine heterogeneous data of different lengths, trimming those to the same number of timepoints (NTPs). However, the effects of trimming blood-oxygen-level dependent (BOLD) signal data on functional connectivity (FC) are still poorly understood.</p><p>Resting-state functional magnetic resonance imaging data from thirty healthy subjects were pre-processed for five different NTPs, from which FC matrices were computed. These BOLD signal correlation matrices were binarized for several thresholds, excluding weak correlations. Graph metrics were computed to study FC differences between different NTPs. The study included node degree analysis for each brain region and assessment of small-worldness coefficients (<span><math><mi>σ</mi></math></span> and <span><math><mi>ω</mi></math></span>), whereas in small-world networks, characteristic values are <span><math><mi>σ</mi></math></span> > 1 and <span><math><mi>ω</mi></math></span> <span><math><mo>≈</mo></math></span> 0, indicating a balance between high clustering coefficients and short characteristic path lengths.</p><p>A tendency of decreasing global network degrees for higher NTPs was observed, translating the loss of stronger correlations with longer BOLD signals. Trimming such data affects brain regions differently, probably due to brain network dynamics. Regarding small-worldness, we observed that <span><math><mi>σ</mi></math></span> was greater than 1 for all the different NTPs, showing an increasing trend for higher NTPs (median value: <span><math><mrow><mspace></mspace><msub><mrow><mi>σ</mi></mrow><mrow><mi>BRAIN</mi></mrow></msub><mo>=</mo></mrow></math></span> 3.05). In addition, <span><math><mi>ω</mi></math></span> consistently remained greater than 0 for all NTPs, gradually approaching 0 as the NTPs increased (median value <span><math><mrow><msub><mrow><mi>ω</mi></mrow><mrow><mi>BRAIN</mi></mrow></msub><mo>=</mo></mrow></math></span> 0.20). As such, the results suggest a tendency for an increase of small-world properties for increasing NTPs. Nonetheless, the overall properties of brain networks almost remain constant. In conclusion, trimming BOLD signal data leads to small differences in FC.</p></div>","PeriodicalId":100198,"journal":{"name":"Brain Organoid and Systems Neuroscience Journal","volume":"2 ","pages":"Pages 1-9"},"PeriodicalIF":0.0,"publicationDate":"2024-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2949921624000012/pdfft?md5=bd5f31baae18e513ed72ef27a5f671ba&pid=1-s2.0-S2949921624000012-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140275891","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-12-01DOI: 10.1016/j.bosn.2023.11.001
Christos Stergiadis , David M. Halliday , Dimitrios Kazis , Manousos A. Klados
Epilepsy is a disease of altered brain networks. The monitoring and analysis of functional connectivity and network properties can yield a better understanding of the underlying pathology, and improve treatment and prognostics. Identifying hub network regions has been in the spotlight of network neuroscience studies in epilepsy, as monitoring these areas can provide a perspective of the network’s local and global organization. Functional network analysis can be especially useful in Medically Refractory Epilepsy (MRE) cases, where surgical intervention is necessary for seizure relief. In such cases, the delineation of the epileptogenic zone, which represents the surgical target, is a very crucial procedure, which can be enhanced by understanding the underlying network topology. In this review, we will explore the expanding body of literature on functional connectivity of interictal intracranial electrophysiologic data, focusing on the interpretation of network properties, global or local, for identifying epileptogenic tissue. We will emphasize functional connectivity at high frequencies (above 80 Hz), as during the past decade High-Frequency Oscillations (HFOs) have been increasingly recognized as a promising biomarker of the seizure onset zone. We will conclude the review with an assessment of current limitations and a discussion of future research paths.
{"title":"Functional connectivity of interictal iEEG and the connectivity of high-frequency components in epilepsy","authors":"Christos Stergiadis , David M. Halliday , Dimitrios Kazis , Manousos A. Klados","doi":"10.1016/j.bosn.2023.11.001","DOIUrl":"https://doi.org/10.1016/j.bosn.2023.11.001","url":null,"abstract":"<div><p>Epilepsy is a disease of altered brain networks. The monitoring and analysis of functional connectivity and network properties can yield a better understanding of the underlying pathology, and improve treatment and prognostics. Identifying hub network regions has been in the spotlight of network neuroscience studies in epilepsy, as monitoring these areas can provide a perspective of the network’s local and global organization. Functional network analysis can be especially useful in Medically Refractory Epilepsy (MRE) cases, where surgical intervention is necessary for seizure relief. In such cases, the delineation of the epileptogenic zone, which represents the surgical target, is a very crucial procedure, which can be enhanced by understanding the underlying network topology. In this review, we will explore the expanding body of literature on functional connectivity of interictal intracranial electrophysiologic data, focusing on the interpretation of network properties, global or local, for identifying epileptogenic tissue. We will emphasize functional connectivity at high frequencies (above 80 Hz), as during the past decade High-Frequency Oscillations (HFOs) have been increasingly recognized as a promising biomarker of the seizure onset zone. We will conclude the review with an assessment of current limitations and a discussion of future research paths.</p></div>","PeriodicalId":100198,"journal":{"name":"Brain Organoid and Systems Neuroscience Journal","volume":"1 ","pages":"Pages 3-12"},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2949921623000029/pdfft?md5=22c9949ed5f1212abc15d2e908316ed1&pid=1-s2.0-S2949921623000029-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138557776","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-10-30DOI: 10.1016/j.bosn.2023.10.001
Manousos Klados, Luisa Pinto
{"title":"Navigating the frontiers of neuroscience","authors":"Manousos Klados, Luisa Pinto","doi":"10.1016/j.bosn.2023.10.001","DOIUrl":"https://doi.org/10.1016/j.bosn.2023.10.001","url":null,"abstract":"","PeriodicalId":100198,"journal":{"name":"Brain Organoid and Systems Neuroscience Journal","volume":"1 ","pages":"Pages 1-2"},"PeriodicalIF":0.0,"publicationDate":"2023-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71714856","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-08-25DOI: 10.51335/organoid.2023.3.e12
J. A. Park, Yunji Lee, Sungjune Jung
Inkjet bioprinting, a derivative of traditional inkjet technology, is gaining recognition in the fields of life sciences and tissue engineering due to its ability to produce picoliter volume droplets at high speeds in a non-contact fashion. This method has impressively evolved from enabling the production of 2-dimensional (2D) prints to complex 3-dimensional (3D) structures, and is increasingly being used in the manufacturing of electronic components. More recently, this technology has been effectively adapted for a variety of medical applications, such as cell patterning, scaffold construction, and 3D tissue fabrication. In this review, we delve into the principles and biological uses of inkjet technology. We provide an in-depth discussion on the latest developments in inkjet bioprinting, with a focus on cell patterning and 3D fabrication of tissue models, including multilayered lung, bladder, and skin. We also explore the potential of high-throughput 3D-bioprinted tissue models in toxicology and drug efficacy testing.
{"title":"Inkjet-based bioprinting for tissue engineering","authors":"J. A. Park, Yunji Lee, Sungjune Jung","doi":"10.51335/organoid.2023.3.e12","DOIUrl":"https://doi.org/10.51335/organoid.2023.3.e12","url":null,"abstract":"Inkjet bioprinting, a derivative of traditional inkjet technology, is gaining recognition in the fields of life sciences and tissue engineering due to its ability to produce picoliter volume droplets at high speeds in a non-contact fashion. This method has impressively evolved from enabling the production of 2-dimensional (2D) prints to complex 3-dimensional (3D) structures, and is increasingly being used in the manufacturing of electronic components. More recently, this technology has been effectively adapted for a variety of medical applications, such as cell patterning, scaffold construction, and 3D tissue fabrication. In this review, we delve into the principles and biological uses of inkjet technology. We provide an in-depth discussion on the latest developments in inkjet bioprinting, with a focus on cell patterning and 3D fabrication of tissue models, including multilayered lung, bladder, and skin. We also explore the potential of high-throughput 3D-bioprinted tissue models in toxicology and drug efficacy testing.","PeriodicalId":100198,"journal":{"name":"Brain Organoid and Systems Neuroscience Journal","volume":"72 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-08-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86307540","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-07-18DOI: 10.51335/organoid.2023.3.e11
Min Jae Lim, A. Jo, Sung-Won Kim
Background: Alveolar organoids may be useful tools in drug discovery for lung diseases, such as chronic obstructive pulmonary disease, and for studying the effects of respiratory viruses, such as severe acute respiratory syndrome coronavirus 2. Induced pluripotent stem cell (iPSC)-derived alveolar organoids offer ethical and cost-effective alternatives to animal testing and primary cell-based methods. In this study, we present generating alveolar organoids from iPSCs and compare the efficiency of generating iPSCs from alveolar type 2 (AT2) and umbilical cord blood (UCB) cells.Methods: The protocol started with a two-dimensional culture and transitioned to a three-dimensional culture using Matrigel after the endoderm stage. Organoid cultivation lasted for at least 40 days, and the characteristics of alveolar organoids were assessed using flow cytometry, real-time polymerase chain reaction, and immunostaining.Results: iPSCs derived from AT2 cells showed a better ability to generate alveolar organoids than those derived from UCB cells. This difference in the ability of AT2 iPSCs and UCB iPSCs to generate alveolar organoids appeared during the definitive endoderm differentiation stage. AT2 iPSCs showed higher expression of the anterior foregut endoderm marker SOX2 and lung progenitor gene expression markers, such as NKX2.1 and CPM, which are associated with the lung progenitor differentiation stage.Conclusion: This protocol successfully generated alveolar organoids from AT2 iPSCs; however, the efficiency of differentiation varied depending on the origin of the iPSCs. This study also found differences in gene expression and developmental potential between iPSCs, which may have contributed to the observed differences in differentiation efficiency.
{"title":"A novel method for generating induced pluripotent stem cell (iPSC)-derived alveolar organoids: a comparison of their ability depending on iPSC origin","authors":"Min Jae Lim, A. Jo, Sung-Won Kim","doi":"10.51335/organoid.2023.3.e11","DOIUrl":"https://doi.org/10.51335/organoid.2023.3.e11","url":null,"abstract":"Background: Alveolar organoids may be useful tools in drug discovery for lung diseases, such as chronic obstructive pulmonary disease, and for studying the effects of respiratory viruses, such as severe acute respiratory syndrome coronavirus 2. Induced pluripotent stem cell (iPSC)-derived alveolar organoids offer ethical and cost-effective alternatives to animal testing and primary cell-based methods. In this study, we present generating alveolar organoids from iPSCs and compare the efficiency of generating iPSCs from alveolar type 2 (AT2) and umbilical cord blood (UCB) cells.Methods: The protocol started with a two-dimensional culture and transitioned to a three-dimensional culture using Matrigel after the endoderm stage. Organoid cultivation lasted for at least 40 days, and the characteristics of alveolar organoids were assessed using flow cytometry, real-time polymerase chain reaction, and immunostaining.Results: iPSCs derived from AT2 cells showed a better ability to generate alveolar organoids than those derived from UCB cells. This difference in the ability of AT2 iPSCs and UCB iPSCs to generate alveolar organoids appeared during the definitive endoderm differentiation stage. AT2 iPSCs showed higher expression of the anterior foregut endoderm marker SOX2 and lung progenitor gene expression markers, such as NKX2.1 and CPM, which are associated with the lung progenitor differentiation stage.Conclusion: This protocol successfully generated alveolar organoids from AT2 iPSCs; however, the efficiency of differentiation varied depending on the origin of the iPSCs. This study also found differences in gene expression and developmental potential between iPSCs, which may have contributed to the observed differences in differentiation efficiency.","PeriodicalId":100198,"journal":{"name":"Brain Organoid and Systems Neuroscience Journal","volume":"49 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76024380","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-06-25DOI: 10.51335/organoid.2023.3.e10
Hye-Youn Kim, Seyoung Yu, Yo Jun Choi, H. Gee
Since the first publication on generating kidney-like cell aggregates from pluripotent stem cells, various modifications have been made to develop more complex and detailed kidney structures. In contrast to earlier models that featured nephron-like structures, these advances have improved the differentiation efficiency and similarity to the human kidney. Presently, kidney organoids contain not only nephrons and ureteric buds but also stromal cells. These organoids mimic the structural similarities and developmental processes of the kidneys, while reflecting their physiological properties. Kidney tubuloids derived from adult stem cells offer the advantage of long-term culture and expansion, but they include only tubular structures and lack glomerular components. In this review, we discuss the induction protocols for kidney organoids and tubuloids, as well as their potential applications in understanding kidney development, renal pathogenesis, and drug screening.
{"title":"Kidney organoids: development and applications","authors":"Hye-Youn Kim, Seyoung Yu, Yo Jun Choi, H. Gee","doi":"10.51335/organoid.2023.3.e10","DOIUrl":"https://doi.org/10.51335/organoid.2023.3.e10","url":null,"abstract":"Since the first publication on generating kidney-like cell aggregates from pluripotent stem cells, various modifications have been made to develop more complex and detailed kidney structures. In contrast to earlier models that featured nephron-like structures, these advances have improved the differentiation efficiency and similarity to the human kidney. Presently, kidney organoids contain not only nephrons and ureteric buds but also stromal cells. These organoids mimic the structural similarities and developmental processes of the kidneys, while reflecting their physiological properties. Kidney tubuloids derived from adult stem cells offer the advantage of long-term culture and expansion, but they include only tubular structures and lack glomerular components. In this review, we discuss the induction protocols for kidney organoids and tubuloids, as well as their potential applications in understanding kidney development, renal pathogenesis, and drug screening.","PeriodicalId":100198,"journal":{"name":"Brain Organoid and Systems Neuroscience Journal","volume":"98 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79258176","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-05-25DOI: 10.51335/organoid.2023.3.e9
Anish Ashok Adpaikar, Jong‐Min Lee, Han-Sung Jung
Background: Taste buds are a complex organ and require a plethora of growth factors for their development, homeostasis, and regeneration. Taste bud organoids provide a platform for understanding their development, disease and regeneration.Methods: In this study, we focused on identifying the localization of receptors involved during taste bud development in taste bud organoids, either in an extracellular matrix scaffold (Matrigel) or in the absence of a scaffold with suspension culture.Results: Compared to Matrigel-cultured organoids, suspension organoids showed stable expression of nerve growth factor receptor (NGFR) cells, which are important for innervation. Transporters for glucose metabolism, such as GLUT1, GLUT2, and the insulin receptor (IGF1R), were observed in suspension-cultured organoids. Furthermore, immunostaining for downstream phosphorylated signaling molecules indicated that the NGFR and IGFR pathways were functional and active in the organoids.Conclusion: Based on these results, suspension-cultured organoids may provide an efficient model for mimicking in vivo taste buds compared to conventional Matrigel organoids.
{"title":"Suspension-cultured taste bud organoids recapitulate in vivo taste buds","authors":"Anish Ashok Adpaikar, Jong‐Min Lee, Han-Sung Jung","doi":"10.51335/organoid.2023.3.e9","DOIUrl":"https://doi.org/10.51335/organoid.2023.3.e9","url":null,"abstract":"Background: Taste buds are a complex organ and require a plethora of growth factors for their development, homeostasis, and regeneration. Taste bud organoids provide a platform for understanding their development, disease and regeneration.Methods: In this study, we focused on identifying the localization of receptors involved during taste bud development in taste bud organoids, either in an extracellular matrix scaffold (Matrigel) or in the absence of a scaffold with suspension culture.Results: Compared to Matrigel-cultured organoids, suspension organoids showed stable expression of nerve growth factor receptor (NGFR) cells, which are important for innervation. Transporters for glucose metabolism, such as GLUT1, GLUT2, and the insulin receptor (IGF1R), were observed in suspension-cultured organoids. Furthermore, immunostaining for downstream phosphorylated signaling molecules indicated that the NGFR and IGFR pathways were functional and active in the organoids.Conclusion: Based on these results, suspension-cultured organoids may provide an efficient model for mimicking in vivo taste buds compared to conventional Matrigel organoids.","PeriodicalId":100198,"journal":{"name":"Brain Organoid and Systems Neuroscience Journal","volume":"112 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-05-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90670115","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-04-25DOI: 10.51335/organoid.2023.3.e5
S. Park, Harshita Sharma, W. Kim, Yonghyun Gwon, H. Kim, Y. Choung, Jangho Kim
In vitro miniaturized organoids are innovative tools with varying applications in biomedical engineering, such as drug testing, disease modeling, organ development studies, and regenerative medicine. However, conventional organoid development has several hurdles in reproducing and reconstituting organ-level functions in vitro, hampering advanced and impactful studies. In this review, we summarize the emerging microengineering-based organoid development techniques aiming to overcome these hurdles. First, we provide basic information on microengineering techniques, including those for reconstituting organoids with organ-level functions. We then focus on recent advances in microengineered organoids with better morphological, physiological, and functional characteristics than conventionally developed organoids. We believe that microengineered organoids possessing organ-level functions in vitro will enable widespread studies in the field of biological sciences and have clinical applications.
{"title":"Microengineered organoids: reconstituting organ-level functions in vitro","authors":"S. Park, Harshita Sharma, W. Kim, Yonghyun Gwon, H. Kim, Y. Choung, Jangho Kim","doi":"10.51335/organoid.2023.3.e5","DOIUrl":"https://doi.org/10.51335/organoid.2023.3.e5","url":null,"abstract":"In vitro miniaturized organoids are innovative tools with varying applications in biomedical engineering, such as drug testing, disease modeling, organ development studies, and regenerative medicine. However, conventional organoid development has several hurdles in reproducing and reconstituting organ-level functions in vitro, hampering advanced and impactful studies. In this review, we summarize the emerging microengineering-based organoid development techniques aiming to overcome these hurdles. First, we provide basic information on microengineering techniques, including those for reconstituting organoids with organ-level functions. We then focus on recent advances in microengineered organoids with better morphological, physiological, and functional characteristics than conventionally developed organoids. We believe that microengineered organoids possessing organ-level functions in vitro will enable widespread studies in the field of biological sciences and have clinical applications.","PeriodicalId":100198,"journal":{"name":"Brain Organoid and Systems Neuroscience Journal","volume":"245 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80578741","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-04-25DOI: 10.51335/organoid.2023.3.e7
Hantai Kim, Young Sun Kim, Y. Kim, Jungho Ha, Siung Sung, J. Jang, S. Park, Jangho Kim, Kyungeun Kim, Y. Choung
The inner ear is responsible for both hearing and balance in the body, and since the initial development of otic (inner ear) organoids from mouse pluripotent stem cells (PSCs) in 2013, significant advances have been made in this field. Bone morphogenetic proteins, fibroblast growth factors, and Wnt agonists, which are signaling molecules in the early development of the inner ear, can induce PSCs into the otic fate. In the inner ear, hair cells and the surrounding supporting cells are essential for proper function and structure. Recent advancements in otic organoid research have enabled the generation of cells that closely resemble these key components. The developed otic organoids contain both hair cell-like cells and supporting cells, which have been confirmed to have the intrinsic function of those cell types. Otic organoids have been used for disease modeling and are expected to be more widely applied in various areas of research on the inner ear. However, the otic organoids developed to date remain immature. Although they mimic hair cells, their properties resemble vestibular (balance) hair cells more closely than cochlear (auditory) hair cells. The ultimate goal of research on the inner ear is hearing restoration and prevention; thus, it is essential to produce otic organoids that contain cochlear hair cells. In addition, the organ of Corti—a cell arrangement unique to the cochlea—has not yet been simulated. Along with a description of the current status of otic organoids, this review article will discuss future directions for otic organoids in inner ear research.
{"title":"Development of otic organoids and their current status","authors":"Hantai Kim, Young Sun Kim, Y. Kim, Jungho Ha, Siung Sung, J. Jang, S. Park, Jangho Kim, Kyungeun Kim, Y. Choung","doi":"10.51335/organoid.2023.3.e7","DOIUrl":"https://doi.org/10.51335/organoid.2023.3.e7","url":null,"abstract":"The inner ear is responsible for both hearing and balance in the body, and since the initial development of otic (inner ear) organoids from mouse pluripotent stem cells (PSCs) in 2013, significant advances have been made in this field. Bone morphogenetic proteins, fibroblast growth factors, and Wnt agonists, which are signaling molecules in the early development of the inner ear, can induce PSCs into the otic fate. In the inner ear, hair cells and the surrounding supporting cells are essential for proper function and structure. Recent advancements in otic organoid research have enabled the generation of cells that closely resemble these key components. The developed otic organoids contain both hair cell-like cells and supporting cells, which have been confirmed to have the intrinsic function of those cell types. Otic organoids have been used for disease modeling and are expected to be more widely applied in various areas of research on the inner ear. However, the otic organoids developed to date remain immature. Although they mimic hair cells, their properties resemble vestibular (balance) hair cells more closely than cochlear (auditory) hair cells. The ultimate goal of research on the inner ear is hearing restoration and prevention; thus, it is essential to produce otic organoids that contain cochlear hair cells. In addition, the organ of Corti—a cell arrangement unique to the cochlea—has not yet been simulated. Along with a description of the current status of otic organoids, this review article will discuss future directions for otic organoids in inner ear research.","PeriodicalId":100198,"journal":{"name":"Brain Organoid and Systems Neuroscience Journal","volume":"12 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82060700","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}